• BTC $8,227.87 (3.12%)
  • ETH $174.96 (1.54%)
  • MARKET CAP $226B
  • ICOs 4,245

Aimedis

UPCOMING 401 views
8.5
Total Rate

Aimedis is an AI backed, blockchain and smart contract supported medical ecosystem, that changes the way patients, doctors, and hospitals communicate, connect and handle information. Using the Aimedis platform, users can store, secure and share their medical information only with the people they want to share it with by using the Aimedis right management system. Beside the records, AImedis offers videochat and communication with other patients and doctors, online prescriptions, online appointments, learning content, the inclusion of fitness trackers and devices like ECG or bloodpressure monitors into the system, while all transactions inside the system are backed by our porprietary private AIMChain blockchain, while the token is bound to a public blockchain (Aimedis dual-blockchain model). AIMSocial will be the new incentivised and decentralized medical social network where patients can help other patients and get rewarded for it, while the system is supported by AI.
General
Website: Visit
White paper: Read
MVP: View
Whitelist/KYC: Whitelist & Kyc
Country: Netherlands
Token Info
Ticker: AIM
Platform: Ethereum
Token type: ERC20
Available for sale: 300,000,000 AIM
Financial
Pre-sale Price: 1 AIM = 0.12 USD
ICO Price: 1 AIM = 0.12 USD
Accepting: ETH
Soft cap: 9,000,000 USD
Hard cap: 36,000,000 USD
Social Media
  • 1

    2016 Q3

    Start of development Aimedis 1.0.

  • 2

    2017 Q3 & Q4

    Launch of Aimedis 1.0 in closed environment.

  • 3

    2017 Q4

    Getting Certified ISO 9001 & ISO 27001. Start of European cooperations SRH hospital group 1.

  • 4

    2018 Q1

    ICO white paper release presale in March.

  • 5

    2018 Q2

    ICO in April. iOS & Android Apps.

  • 6

    2018 Q3

    Start of Asian cooperation program.

  • 7

    2018 Q4

    Launch of Aimedis 2.0.

  • 8

    2019 Q2

    Incetivised patient AIMSocial platform.

  • 9

    2019 Q3

    AIMedisafe secure pharma label.

  • 10

    2019 Q4

    AIMedisafe backed online drugstore.

  • 11

    2020 Q1

    Release of Aimedis 3.0 with AI backed diagnosis & therapy program.

Michael J. Kaldasch

CEO, MD & founder

Ben El Idrissi

COO, MD & founder

Sankar Ghanesh

CTO

Lazaros Fountoukidis

CMO & MD

Roxana Nasoi

CCO

Stefan F. Krieg

Physicist - HPC, deep learning & AI

Lin Wan

Head of IT & development

Amer Mufti

Head of Silicon Valley office - lead blockchain development

Sebastian Wehkamp

CDO & creative director

Benjamin Bergmann

CSO

Sopia Singdee

BD Asia

Catherine Angcaya

CFO

Daria Borisenko

BD Russia, Belarus & Ukraine

BingFeng Liu

Full stack developer

ZiLong Sun

Full stack mobile developer

Markus Moench

Full stack developer

Gang Zhu

Full stack developer

Yang Chul

Boering Projectleader cardiology & MD

Put this code to your website

Width: 420px-Height: 210px
comments powered by Disqus
Hot and trending ICOs
This website is using cookies. More info.